MiNK Therapeutics, Inc. INKT
12.18
(0.12)
(0.98%)
as of 25 Sep
- Market cap
- $62.8M
- P/E
- 0.0×
Follow INKT
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
1.23 | 1.38 | 1.06 | 1.08 |
+8 more quarters Free account |
Net Debt/EBITDA |
2.77 | 3.35 | 5.01 | 4.55 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.67 | 0.63 | 0.80 | 0.33 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.41) | (0.36) | (0.49) | (0.21) | |
Cash per Share |
1.75 | 1.99 | 3.13 | 3.21 | |
Shareholders Equity per Share |
(2.79) | (2.64) | (3.33) | (3.04) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(2.79) | (2.64) | (3.33) | (3.04) | |
Free Cash Flow |
(2.08) | (1.73) | (2.07) | (0.94) | |
Working Capital |
1.73 | 2.74 | 0.82 | 1.10 | |
Net Current Asset Value |
(14.35) | (13.04) | (14.62) | (13.94) | |
| Other line items | |||||
Quick Ratio |
1.16 | 1.31 | 1.03 | 1.06 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.41) | (0.36) | (0.49) | (0.21) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
3.62 | 3.03 | 3.08 | 3.03 | |
Average Assets |
6.05 | 7.32 | 9.98 | 11.17 | |
Average Common Equity |
(19.61) | (17.24) | (16.91) | (15.53) | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates